NasdaqCM - Delayed Quote • USD
Sonoma Pharmaceuticals, Inc. (SNOA)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:07 PM EDT
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
12,310.0000
13,272.0000
12,628.0000
18,629.0000
Cost of Revenue
7,792.0000
8,795.0000
8,635.0000
12,070.0000
Gross Profit
4,518.0000
4,477.0000
3,993.0000
6,559.0000
Operating Expense
8,957.0000
9,047.0000
9,880.0000
10,008.0000
Operating Income
-4,439.0000
-4,570.0000
-5,887.0000
-3,449.0000
Net Non Operating Interest Income Expense
--
16.0000
-10.0000
4.0000
Other Income Expense
-688.0000
-630.0000
479.0000
-457.0000
Pretax Income
-5,111.0000
-5,184.0000
-5,418.0000
-3,902.0000
Tax Provision
-35.0000
-33.0000
-332.0000
713.0000
Net Income Common Stockholders
-5,076.0000
-5,151.0000
-5,086.0000
-3,950.0000
Diluted NI Available to Com Stockholders
-5,076.0000
-5,151.0000
-5,086.0000
-3,950.0000
Basic EPS
-0.82
-1.52
-1.92
-1.97
Diluted EPS
-0.82
-1.52
-1.92
-1.97
Basic Average Shares
6,324.2500
3,394.0000
2,653.0000
1,996.0000
Diluted Average Shares
6,324.2500
3,394.0000
2,653.0000
1,996.0000
Total Operating Income as Reported
-4,439.0000
-4,570.0000
-5,887.0000
-3,449.0000
Total Expenses
16,749.0000
17,842.0000
18,515.0000
22,078.0000
Net Income from Continuing & Discontinued Operation
-5,076.0000
-5,151.0000
-5,086.0000
-3,950.0000
Normalized Income
-5,076.9932
-5,151.9940
-5,904.8740
-4,715.0100
Interest Income
--
--
--
16.0000
Interest Expense
--
--
--
12.0000
Net Interest Income
--
16.0000
-10.0000
4.0000
EBIT
-4,439.0000
-4,570.0000
-5,887.0000
-3,449.0000
EBITDA
-4,270.0000
-4,445.0000
-5,701.0000
-3,222.0000
Reconciled Cost of Revenue
7,792.0000
8,795.0000
8,635.0000
12,070.0000
Reconciled Depreciation
169.0000
125.0000
186.0000
227.0000
Net Income from Continuing Operation Net Minority Interest
-5,076.0000
-5,151.0000
-5,086.0000
-4,615.0000
Total Unusual Items Excluding Goodwill
1.0000
1.0000
873.0000
137.0000
Total Unusual Items
1.0000
1.0000
873.0000
137.0000
Normalized EBITDA
-4,271.0000
-4,446.0000
-6,574.0000
-3,359.0000
Tax Rate for Calcs
0.0000
0.0000
0.0001
0.0003
Tax Effect of Unusual Items
0.0068
0.0060
54.1260
36.9900
3/31/2021 - 1/25/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LSDI Lucy Scientific Discovery Inc.
0.7597
-12.58%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3850
-0.90%
BFRI Biofrontera Inc.
1.5900
-7.02%
SXTC China SXT Pharmaceuticals, Inc.
1.0500
+1.94%
PTPI Petros Pharmaceuticals, Inc.
0.6399
0.00%
BGXX Bright Green Corporation
0.1996
+8.48%
ORGO Organogenesis Holdings Inc.
2.3500
+2.84%
PRFX PainReform Ltd.
0.8101
-2.40%
AKAN Akanda Corp.
0.1030
+12.57%
ALIM Alimera Sciences, Inc.
3.4900
+5.44%